Atlas Trials

EFFECT OF SELECTIVE COX-2 INHIBITOR (ETORICOXIB) ALONG WITH SCALING AND ROOT PLANING (SRP) ON CLINICAL PARAMETERS AND SALIVARY LEVEL OF SUPEROXIDE DISMUTASE IN CHRONIC GENERALIZED PERIODONTITIS A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOUBLE-MASKED RANDOMIZED CONTROLLED TRIAL (RCT).

Clinical trial NCT02149758 · COMPLETED

Trial details

NCT number
NCT02149758
Sponsor
Tatyasaheb Kore Dental College
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Cyclooxygenase Two InhibitorsEtoricoxibPeriodontitisSuperoxide DismutaseSaliva
Start date
2013-01-01
Primary completion
2013-06-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.